» Articles » PMID: 26667650

Impaired Health-Related Quality of Life in Children and Families Affected by Methylmalonic Acidemia

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2015 Dec 16
PMID 26667650
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

An understanding of health related quality of life (HRQoL) in children and families affected by methylmalonic acidemia (MMA) is important in planning counseling and therapeutic intervention. Liver transplantation (LT) is used as a treatment for MMA; however, its risks and benefits continue to be investigated. The purpose of this study was twofold: (1) to measure HRQoL in children and families affected by MMA using the Pediatric Quality of Life Inventory (PedsQL™) parent version, and (2) to assess the impact of LT on HRQoL by comparing LT and non-LT patient scores and free responses. Parents/caregivers reported lower scores on the majority of the PedsQL™ scales as compared to samples of healthy children, children with solid organ transplants for indications other than MMA, and families affected by chronic conditions. Scores for children with MMA were lowest in school and social functioning and scores for families were lowest in worry and activity impairment. There were no significant differences in LT and non-LT patient scores on the PedsQL™ scales. Our results document the negative impact of MMA on HRQoL.

Citing Articles

Psychosocial Challenges Facing Young People With Inherited Metabolic Disorders and Their Parents: A Systematic Review.

Sherlock C, Clarke K, Jordan N JIMD Rep. 2025; 66(2):e70000.

PMID: 40012903 PMC: 11860279. DOI: 10.1002/jmd2.70000.


Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN.

Servais A, Zacchia M, Dehoux L, Shroff R, Brassier A, Taurisano R Kidney Int Rep. 2024; 9(12):3362-3374.

PMID: 39698355 PMC: 11652068. DOI: 10.1016/j.ekir.2024.09.002.


An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.

Bretos-Azcona P, Wallace M, Jootun M, Jin G, Agirrezabal I, Szende A Clin Drug Investig. 2024; 44(6):399-412.

PMID: 38796677 DOI: 10.1007/s40261-024-01363-1.


Advance Care Planning for Children With Rare Diseases: A Pilot RCT.

Lyon M, Fraser J, Thompkins J, Clark H, Brodie N, Detwiler K Pediatrics. 2024; 153(6).

PMID: 38699801 PMC: 11153326. DOI: 10.1542/peds.2023-064557.


Measuring health-related quality of life in children with suspected genetic conditions: validation of the PedsQL proxy-report versions.

Smith H, Leo M, Goddard K, Muessig K, Angelo F, Knight S Qual Life Res. 2024; 33(6):1541-1553.

PMID: 38472717 PMC: 11116065. DOI: 10.1007/s11136-024-03623-1.


References
1.
Kayler L, Merion R, Lee S, Sung R, Punch J, Rudich S . Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant. 2002; 6(4):295-300. DOI: 10.1034/j.1399-3046.2002.02009.x. View

2.
Heidenreich R, Natowicz M, Hainline B, Berman P, Kelley R, Hillman R . Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus. J Pediatr. 1988; 113(6):1022-7. DOI: 10.1016/s0022-3476(88)80574-2. View

3.
Weissberg-Benchell J, Zielinski T, Rodgers S, Greenley R, Askenazi D, Goldstein S . Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module. Am J Transplant. 2010; 10(7):1677-85. DOI: 10.1111/j.1600-6143.2010.03149.x. View

4.
Leonard J . The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis. 1995; 18(4):430-4. DOI: 10.1007/BF00710054. View

5.
Vant Hoff W, McKiernan P, Surtees R, Leonard J . Liver transplantation for methylmalonic acidaemia. Eur J Pediatr. 1999; 158 Suppl 2:S70-4. DOI: 10.1007/pl00014326. View